PND40 BUDGET IMPACT ANALYSIS OF GALCANEZUMAB-GNLM FOR THE PREVENTIVE TREATMENT OF PATIENTS WITH CHRONIC AND EPISODIC MIGRAINE IN THE UNITED STATES
Abstract
Authors
S.A. Foster S. Milev M. Hoog O. Mason A. Sardesai A. Hasan C. Marrone